APA (7th ed.) Citation

Schnittger, S., Bacher, U., Haferlach, C., Kern, W., & Haferlach, T. (2007). Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: A study on 162 patients. Leukemia (08876924), 21(4), 725. https://doi.org/10.1038/sj.leu.2404531

Chicago Style (17th ed.) Citation

Schnittger, S., U. Bacher, C. Haferlach, W. Kern, and T. Haferlach. "Rare CBFB-MYH11 Fusion Transcripts in AML with Inv(16)/t(16;16) Are Associated with Therapy-related AML M4eo, Atypical Cytomorphology, Atypical Immunophenotype, Atypical Additional Chromosomal Rearrangements and Low White Blood Cell Count: A Study on 162 Patients." Leukemia (08876924) 21, no. 4 (2007): 725. https://doi.org/10.1038/sj.leu.2404531.

MLA (9th ed.) Citation

Schnittger, S., et al. "Rare CBFB-MYH11 Fusion Transcripts in AML with Inv(16)/t(16;16) Are Associated with Therapy-related AML M4eo, Atypical Cytomorphology, Atypical Immunophenotype, Atypical Additional Chromosomal Rearrangements and Low White Blood Cell Count: A Study on 162 Patients." Leukemia (08876924), vol. 21, no. 4, 2007, p. 725, https://doi.org/10.1038/sj.leu.2404531.